Category — News Feeds

Results of a newly-published study showed that adding rituximab to mycophenolate mofetil and corticosteroids does not improve outcomes in patients with lupus nephritis. Rituximab is approved for treating Non-Hodgkin’s lymphoma, a type of cancer of the immune system.

Full Story

A “genetic accelerator” is responsible for the most severe cases of Lupus (systemic lupus erythemathosus), an autoimmune disease: the accelerator, called enhancer HS1.2, speeds up the activity of some critical genes of the immune system involved in the disease. A team of Italian researchers at the Catholic University of Sacred Heart in Rome found that the enhancer HS1…